Testing clot-busting drug on brain bleed blood samples
Part of Blood & lymphatic, Brain & nervous system, Heart & circulation clinical trials.
This study collects blood samples from people with and without bleeding risk to test a clot-dissolving drug (tPA) outside the body. It aims to improve minimally invasive surgery for brain hemorrhages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are willing to give written permission to participate
- You are receiving regular outpatient medical care
- You either have no known bleeding risk OR you have a bleeding risk from blood thinners, a bleeding disorder, low platelets, or need clotting treatment
- You can provide an extra blood sample (about 2 tablespoons) during a routine visit
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
This study looks at how inflammation and changes in the blood-brain barrier occur after a spontaneous brain bleed. Researchers use special brain imaging and scans to understand these processes, which may help improve treatment in the future.
This trial studies how certain proteins in the blood affect brain inflammation after a small brain bleed (intracerebral hemorrhage). It aims to find new ways to reduce inflammation and improve recovery.
This study tests a new disposable tube with a camera (endoscope) that doctors use to remove a blood clot from the brain after a bleeding stroke. It is designed for people who are stable enough for surgery and whose bleed is in a part of the brain that is reachable with this tool.
This study tests whether a combination of blood pressure medicines can reduce swelling after a brain bleed (intracerebral hemorrhage). It aims to help patients who are treated early—within 3 days of symptom onset—and are not having surgery to remove the clot.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.